Cargando…

Gene Expression Analysis of Biphasic Pleural Mesothelioma: New Potential Diagnostic and Prognostic Markers

Biphasic is the second most common histotype of pleural mesothelioma (PM). It shares epithelioid and sarcomatoid features and is challenging to diagnose. The aim of this study was to identify biphasic PM markers to improve subtyping and prognosis definition. The expression levels of 117 cancer genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruno, Rossella, Poma, Anello Marcello, Alì, Greta, Distefano, Claudia, Proietti, Agnese, Chella, Antonio, Lucchi, Marco, Melfi, Franca, Franco, Renato, Fontanini, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947498/ https://www.ncbi.nlm.nih.gov/pubmed/35328227 http://dx.doi.org/10.3390/diagnostics12030674

Ejemplares similares

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping
por: Di Stefano, Iosè, et al.
Publicado: (2023)

Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis
por: Bruno, Rossella, et al.
Publicado: (2016)

Prevalence of Delta-Like Protein 3 in a Consecutive Series of Surgically Resected Lung Neuroendocrine Neoplasms
por: Alì, Greta, et al.
Publicado: (2021)

Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas
por: Alì, Greta, et al.
Publicado: (2019)

Biomarkers and Gene Signatures to Predict Durable Response to Pembrolizumab in Non-Small Cell Lung Cancer
por: Poma, Anello Marcello, et al.
Publicado: (2021)

SMARCA4 as a support for the differential diagnosis of poorly differentiated lung carcinomas
por: Panozzi, Martina, et al.
Publicado: (2023)

Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer
por: Alì, Greta, et al.
Publicado: (2023)

Hippo pathway affects survival of cancer patients: extensive analysis of TCGA data and review of literature
por: Poma, Anello Marcello, et al.
Publicado: (2018)

Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report
por: Bruno, Rossella, et al.
Publicado: (2017)

Inflammatory Profiles of Tracheal Biopsies From SARS-CoV-2 Patients
por: Fiacchini, Giacomo, et al.
Publicado: (2022)

A Single Liver Metastasis from Pleural Biphasic Mesothelioma
por: Marzullo, Andrea, et al.
Publicado: (2020)

P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
por: BOLDRINI, LAURA, et al.
Publicado: (2015)

Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients
por: Boldrini, Laura, et al.
Publicado: (2018)

Expression of miRNA-25 in young and old lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2021)

Metastatic biphasic pleural mesothelioma presenting with cauda equina syndrome
por: Pranay, Pritesh, et al.
Publicado: (2018)

Biphasic Malignant Pleural Mesothelioma Masquerading as a Primary Skeletal Tumor
por: Gleason, James Benjamin, et al.
Publicado: (2016)

Comparative proteomic analysis of malignant pleural mesothelioma: Focusing on the biphasic subtype
por: Giusti, Laura, et al.
Publicado: (2016)

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
por: Bruno, Rossella, et al.
Publicado: (2021)

New Insights in Pleural Mesothelioma Classification Update: Diagnostic Traps and Prognostic Implications
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2022)

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
por: Alì, G, et al.
Publicado: (2009)

Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma
por: Boldrini, Laura, et al.
Publicado: (2017)

Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report
por: ALÌ, GRETA, et al.
Publicado: (2015)

Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021)

A Biphasic Pleural Tumor with Features of an Epithelioid and Small Cell Mesothelioma: Morphologic and Molecular Findings
por: Hackman, Sarah, et al.
Publicado: (2016)

Predictive Biomarkers in Thyroid Cancer
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Limited Accuracy of Pan-Trk Immunohistochemistry Screening for NTRK Rearrangements in Follicular-Derived Thyroid Carcinoma
por: Macerola, Elisabetta, et al.
Publicado: (2022)

Editorial: Advances in malignant pleural mesothelioma: Diagnosis, treatment, and molecular mechanisms
por: Mastromarino, Maria Giovanna, et al.
Publicado: (2023)

Deep Sequencing Analysis Identified a Specific Subset of Mutations Distinctive of Biphasic Malignant Pleural Mesothelioma
por: Torricelli, Federica, et al.
Publicado: (2020)

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
por: Macerola, Elisabetta, et al.
Publicado: (2021)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

Glomus tumor of the shoulder: A case report and review of the literature
por: PROIETTI, AGNESE, et al.
Publicado: (2013)

Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells
por: Manente, Arcangela G., et al.
Publicado: (2015)

Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor
por: Salazar, Carlos, et al.
Publicado: (2018)

Hyperthermic Intrathoracic Chemotherapy for Malignant Pleural Mesothelioma: The Forefront of Surgery-Based Multimodality Treatment
por: Aprile, Vittorio, et al.
Publicado: (2021)

Spatially resolved, high-dimensional transcriptomics sorts out the evolution of biphasic malignant pleural mesothelioma: new paradigms for immunotherapy
por: Torricelli, F, et al.
Publicado: (2023)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Clinical-Pathological and Molecular Evaluation of 451 NIFTP Patients from a Single Referral Center
por: Vignali, Paola, et al.
Publicado: (2022)

Outcomes of the Tall-Cell Variant of Papillary Thyroid Carcinoma in Patients with Different Ages: A 17-Year Mono-Institutional Experience
por: Proietti, Agnese, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e5ualbqk29ttviif01p23u7l5c